Table 4 Expression level of p53, Bax and Bcl2 genes in the untreated control and treated hepatic cancer Hep-G2 cells with doxorubicin and frankincense nano-emulsion.
Treatment | Concentration | p53 gene | Bax gene | Bcl2 gene |
---|---|---|---|---|
Untreated cells | 0.00 | 1.00 ± 0.00 a | 1.00 ± 0.00 a | 1.00 ± 0.00 a |
Doxorubicin | 2 µM | 2.43 ± 0.13 b | 1.84 ± 0.10 b | 0.95 ± 0.06 a |
Frankincense nano-emulsion | 44.03 µg/ml | 1.87 ± 0.11 c | 1.66 ± 0.07 b | 0.82 ± 0.05 b |
88.07 µg/ml | 2.62 ± 0.20 c | 2.39 ± 0.06 c | 0.65 ± 0.04 c | |
176.14 µg/ml | 3.49 ± 0.19 d | 3.16 ± 0.21 d | 0.49 ± 0.06 d | |
ANOVA | F = 117.03 p < 0.001 | F = 161.48 p < 0.001 | F = 52.65 p < 0.001 |